Previous close | 120.40 |
Open | 121.79 |
Bid | 122.05 x 300 |
Ask | 122.18 x 200 |
Day's range | 119.43 - 122.34 |
52-week range | 62.55 - 170.47 |
Volume | |
Avg. volume | 3,935,358 |
Market cap | 46.797B |
Beta (5Y monthly) | 1.66 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Investors will likely focus on updates on Moderna's (MRNA) pipeline, especially its late-stage pipeline candidates when it reports second-quarter earnings.
Beam Therapeutics (BEAM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Many Moderna, Inc. ( NASDAQ:MRNA ) insiders ditched their stock over the past year, which may be of interest to the...